fluorobenzenes has been researched along with Hepatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, MH | 2 |
2 other study(ies) available for fluorobenzenes and Hepatitis
| Article | Year |
|---|---|
Rosuvastatin as treatment for non alcoholic steatohepatitis (NASH) and highly active antiretroviral therapy (HAART)-dyslipidaemia: new treatment for global dangers.
Topics: Antiretroviral Therapy, Highly Active; Dyslipidemias; Fluorobenzenes; Hepatitis; Humans; Lipoproteins, LDL; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2006 |
Rosuvastatin: a safe and effective treatment for dyslipidaemia associated with non-alcoholic steatohepatitis (NASH).
Topics: Dyslipidemias; Fluorobenzenes; Hepatitis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Pyrimidines; Rosuvastatin Calcium; Steatitis; Sulfonamides | 2006 |